GNOM vs. BOUT ETF Comparison
Comparison of Global X Genomics & Biotechnology ETF (GNOM) to Innovator IBD Breakout Opportunities ETF (BOUT)
GNOM
Global X Genomics & Biotechnology ETF
GNOM Description
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$9.83
Average Daily Volume
43,119
40
BOUT
Innovator IBD Breakout Opportunities ETF
BOUT Description
The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index"). The fund will normally invest at least 80% of its net assets (including investment borrowings) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock's recent "resistance level," with consideration for various market conditions. The fund is non-diversified. BOUT uses technical analysis to find stocks that are likely to breakout. The funds index relies on an algorithm that establishes a base price (a recent high) for each eligible security. The index then follows the trend for each stock. Selected stocks are ranked by a combination of relative strength and fundamental factors, and then weighted in fixed tiers according to this ranking. In addition, BOUT will move 50% of its portfolio into T-bills based on market signals: a rapid increase in either margin debt or overall stock prices, combined with slowing reversing momentum in the S&P 500. The T-bill position will remain in place until the S&P 500 falls by 50% or show indications of rising momentum. BOUT is rebalanced and reconstituted weekly after the close on Friday. The frequent rebalance schedule means the fund will be highly responsive to the technical factors that drive its strategy, but could also experience high turnover.Grade (RS Rating)
Last Trade
$40.14
Average Daily Volume
2,990
44
Performance
| Period | GNOM | BOUT |
|---|---|---|
| 30 Days | -8.90% | 7.95% |
| 60 Days | -13.16% | 9.94% |
| 90 Days | -14.89% | 9.81% |
| 12 Months | -5.98% | 32.83% |
1 Overlapping Holdings
| Symbol | Grade | Weight in GNOM | Weight in BOUT | Overlap | |
|---|---|---|---|---|---|
| CDNA | D | 2.13% | 1.24% | 1.24% |
GNOM Overweight 39 Positions Relative to BOUT
| Symbol | Grade | Weight | |
|---|---|---|---|
| VCYT | B | 4.69% | |
| CRSP | D | 4.66% | |
| NTRA | A | 4.41% | |
| ARWR | D | 4.31% | |
| TECH | F | 4.21% | |
| ILMN | C | 4.14% | |
| QGEN | D | 4.09% | |
| RNA | C | 4.06% | |
| BEAM | D | 4.03% | |
| A | D | 3.93% | |
| BNTX | C | 3.83% | |
| BMRN | F | 3.71% | |
| ALNY | D | 3.71% | |
| RARE | F | 3.63% | |
| LEGN | D | 3.56% | |
| SRPT | F | 3.55% | |
| NTLA | F | 3.23% | |
| MRNA | F | 3.13% | |
| TXG | F | 2.93% | |
| MYGN | F | 2.8% | |
| RCKT | F | 2.62% | |
| GILD | C | 2.17% | |
| VRTX | D | 2.09% | |
| VIR | D | 1.61% | |
| MRVI | F | 1.26% | |
| PACB | F | 1.18% | |
| SGMO | C | 0.99% | |
| RGNX | D | 0.95% | |
| ALLO | F | 0.79% | |
| VERV | F | 0.74% | |
| FLGT | F | 0.73% | |
| SANA | F | 0.65% | |
| QURE | C | 0.64% | |
| EDIT | F | 0.5% | |
| PSTX | D | 0.44% | |
| CRBU | D | 0.42% | |
| TSVT | F | 0.41% | |
| LYEL | F | 0.31% | |
| SCLX | F | 0.01% |
GNOM Underweight 43 Positions Relative to BOUT
| Symbol | Grade | Weight | |
|---|---|---|---|
| PACS | F | -4.48% | |
| MS | A | -4.47% | |
| LBRDK | C | -4.44% | |
| NEM | D | -4.42% | |
| VIK | B | -4.39% | |
| EXPE | B | -4.28% | |
| EQIX | A | -4.25% | |
| AHR | A | -4.24% | |
| IDCC | B | -4.01% | |
| ETN | A | -3.82% | |
| SPGI | C | -3.81% | |
| EQH | C | -3.78% | |
| CRM | B | -3.73% | |
| BAH | F | -3.73% | |
| DVA | C | -3.71% | |
| PGR | A | -3.63% | |
| CRDO | B | -2.87% | |
| VRNS | D | -2.61% | |
| ULS | B | -2.59% | |
| IR | B | -2.49% | |
| DT | D | -2.49% | |
| NMIH | C | -2.44% | |
| ONON | A | -2.35% | |
| COLL | F | -2.23% | |
| TSM | B | -1.31% | |
| TBBK | B | -1.28% | |
| NOW | A | -1.27% | |
| SCCO | F | -1.22% | |
| SN | D | -1.2% | |
| TCOM | B | -1.14% | |
| BEKE | D | -1.06% | |
| ROAD | B | -0.45% | |
| AXON | A | -0.43% | |
| TPH | D | -0.42% | |
| IBKR | A | -0.42% | |
| CWAN | B | -0.42% | |
| AVGO | D | -0.42% | |
| ALKT | B | -0.42% | |
| GMED | A | -0.41% | |
| CORT | B | -0.41% | |
| ACGL | C | -0.4% | |
| PLMR | A | -0.39% | |
| JD | D | -0.38% |
GNOM: Top Represented Industries & Keywords
BOUT: Top Represented Industries & Keywords
Compare ETFs
